Merck & Co., Inc.
MRK · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $251,883 | $284,231 | $280,925 | $193,899 |
| - Cash | $13,242 | $6,841 | $12,694 | $8,096 |
| + Debt | $38,270 | $36,268 | $31,985 | $34,631 |
| Enterprise Value | $276,911 | $313,658 | $300,216 | $220,434 |
| Revenue | $64,168 | $60,115 | $59,283 | $48,704 |
| % Growth | 6.7% | 1.4% | 21.7% | – |
| Gross Profit | $48,975 | $43,989 | $41,872 | $35,078 |
| % Margin | 76.3% | 73.2% | 70.6% | 72% |
| EBITDA | $25,706 | $6,907 | $21,315 | $17,899 |
| % Margin | 40.1% | 11.5% | 36% | 36.8% |
| Net Income | $17,117 | $365 | $14,519 | $13,049 |
| % Margin | 26.7% | 0.6% | 24.5% | 26.8% |
| EPS Diluted | 6.74 | 0.14 | 5.71 | 5.14 |
| % Growth | 4,714.3% | -97.5% | 11.1% | – |
| Operating Cash Flow | $21,468 | $13,006 | $19,095 | $14,109 |
| Capital Expenditures | -$3,372 | -$3,863 | -$4,388 | -$4,448 |
| Free Cash Flow | $18,096 | $9,143 | $14,707 | $9,661 |